Form 4: Roivant Sciences Executive Transfers 3.65 Million Shares for Estate Planning

Mayukh Sukhatme, President and Chief Investment Officer of Roivant Sciences, transferred 3,651,985 common shares for estate planning purposes.

Summary

• Mayukh Sukhatme, President and Chief Investment Officer of Roivant Sciences, transferred 3,651,985 common shares on December 3, 2024.
• The shares were transferred at a price of $12.205 per share.
• The transfer was made for estate planning purposes to a newly formed limited liability company.
• Sukhatme does not have any voting or investment control over the limited liability company.
• Following the transaction, Sukhatme still beneficially owns 18,836,547 common shares.

Sentiment

Score: 5

Explanation: The document is a routine filing of a share transfer for estate planning purposes and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to executive share transactions and is not indicative of any broader industry trends.

Comparison to Industry Standards

• Executive share transfers are common among publicly traded companies and are often related to personal financial planning.
• The transaction is similar to other Form 4 filings where executives report changes in their beneficial ownership of company stock.
• The size of the transaction is not unusual for an executive of a company of Roivant's size.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors as it is a personal transaction for estate planning purposes.

Key Dates

Keywords

Roivant Sciences, Mayukh Sukhatme, share transfer, estate planning, beneficial ownership, common shares, executive transaction